The chemical class known as neurexin II activators encompasses a range of compounds that can potentially upregulate or enhance the activity of neurexin II, a protein that plays a crucial role in synaptic formation and maintenance in the nervous system. These activators are not a homogeneous group but rather a collection of diverse molecules that may impact neurexin II through various mechanisms. The term 'activator' in this context typically refers to substances that increase the expression, stability, or functional activity of neurexin II. The increase in expression could be due to the enhanced transcription of the neurexin II gene, stabilization of its mRNA, or by hindering the degradation pathways that would normally break down the neurexin II protein. Furthermore, some activators might bind directly to neurexin II, changing its conformation in a way that promotes its interaction with other synaptic proteins, such as neuroligins, thereby influencing synaptic plasticity and function.
Within this class, the molecules might act at the genetic level to promote gene expression, or they may function post-translationally to prevent protein degradation or facilitate proper protein folding and trafficking to the synapse. The changes brought about by these activators can affect the synaptic architecture by modulating the abundance of neurexin II at synaptic junctions. This modulation can influence the synapse's ability to adapt to changes, a fundamental process for synaptic signaling and plasticity. Neurexin II activators could potentially affect the presynaptic neuron's ability to release neurotransmitters in response to an action potential, which in turn might affect the overall synaptic transmission efficacy. Since neurexin II is implicated in the precise connection between neurons, the activators have a significant role in ensuring the integrity of these connections, potentially affecting the complex network of neuronal communication and the plasticity of neural circuits.
関連項目
产品名称 | CAS # | 产品编号 | 数量 | 价格 | 应用 | 排名 |
---|---|---|---|---|---|---|
Valproic Acid | 99-66-1 | sc-213144 | 10 g | $85.00 | 9 | |
可能会通过诱导组蛋白乙酰化来增加神经肽 II 的转录,从而在其基因周围形成更易获得的染色质状态。 | ||||||
5-Aza-2′-Deoxycytidine | 2353-33-5 | sc-202424 sc-202424A sc-202424B | 25 mg 100 mg 250 mg | $214.00 $316.00 $418.00 | 7 | |
可通过减少神经肽 II 基因启动子的甲基化作用,增强转录,从而上调神经肽 II。 | ||||||
Bortezomib | 179324-69-7 | sc-217785 sc-217785A | 2.5 mg 25 mg | $132.00 $1064.00 | 115 | |
如果神经肽酶 II 是蛋白酶体的靶标,则可能通过抑制蛋白酶体介导的降解间接提高神经肽酶 II 的水平。 | ||||||
Lithium | 7439-93-2 | sc-252954 | 50 g | $214.00 | ||
可能通过影响细胞内调控基因转录的信号通路来调节神经肽 II 的表达。 | ||||||
Cyclosporin A | 59865-13-3 | sc-3503 sc-3503-CW sc-3503A sc-3503B sc-3503C sc-3503D | 100 mg 100 mg 500 mg 10 g 25 g 100 g | $62.00 $90.00 $299.00 $475.00 $1015.00 $2099.00 | 69 | |
可通过调节参与神经元功能的细胞内信号通路来影响神经肽 II 的表达。 | ||||||
Eicosa-5Z,8Z,11Z,14Z,17Z-pentaenoic Acid (20:5, n-3) | 10417-94-4 | sc-200766 sc-200766A | 100 mg 1 g | $102.00 $423.00 | ||
可能会通过改变膜流动性和相关信号通路影响神经肽 II 的表达。 | ||||||
Docosa-4Z,7Z,10Z,13Z,16Z,19Z-hexaenoic Acid (22:6, n-3) | 6217-54-5 | sc-200768 sc-200768A sc-200768B sc-200768C sc-200768D | 100 mg 1 g 10 g 50 g 100 g | $92.00 $206.00 $1744.00 $7864.00 $16330.00 | 11 | |
可能会通过改变神经元膜组成和细胞信号级联来影响神经肽 II 的表达。 | ||||||
Retinoic Acid, all trans | 302-79-4 | sc-200898 sc-200898A sc-200898B sc-200898C | 500 mg 5 g 10 g 100 g | $65.00 $319.00 $575.00 $998.00 | 28 | |
可能会调节神经肽 II 的表达,这是其在神经元分化过程中调节基因表达作用的一部分。 | ||||||
PMA | 16561-29-8 | sc-3576 sc-3576A sc-3576B sc-3576C sc-3576D | 1 mg 5 mg 10 mg 25 mg 100 mg | $40.00 $129.00 $210.00 $490.00 $929.00 | 119 | |
可能会通过激活参与基因表达调控的蛋白激酶 C 来上调神经肽 II。 |